Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure
This trial has been completed.
|Treatment||iodinated contrast agents|
|Start date||June 2016|
|End date||August 2016|
|Trial size||843 participants|
|Trial identifier||NCT02766283, 18614|
To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice setting.
children age 0-3 years (inclusive), who underwent a iodine contrast enhanced radiological examination.
Number of pediatric patients with detected hypothyroidism after iodinated contrast exposure in a routine clincial practice setting.
time frame: Up to one year after exposure
Male or female participants up to 3 years old.
- All children age 0-3 years (inclusive) who are identified of having undergone a radiological examination with intravascular use of an iodinated contrast agent.(e.g. contrast enhanced CT, cardioangiography)
- Congenital Hypothyroidism or other forms of preexisting hypothyroidism
- Preexisting thyroid hormone replacement therapy less than three months of observation before the radiological examination (if greater than three months old)
- Less than two weeks follow-up available after the contrast exposure.
|Official title||Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure|
Call for more information